First-Line Antibiotic Choice for Adult Impetigo
For adults with impetigo, oral cephalexin (500 mg four times daily for 7 days) or dicloxacillin (500 mg four times daily for 7 days) are the first-line antibiotic choices for methicillin-susceptible Staphylococcus aureus (MSSA), while topical mupirocin ointment applied twice daily for 5 days is preferred for limited disease. 1
Treatment Algorithm Based on Disease Extent
Limited Disease (Few Lesions)
- Topical mupirocin 2% ointment applied twice daily for 5 days is the preferred first-line treatment 1
- Topical retapamulin ointment applied twice daily is an alternative 1
- Topical therapy may be superior to oral antibiotics for limited impetigo 2, 3
Extensive Disease (Numerous Lesions)
- Oral antibiotics are recommended when patients have numerous lesions or during outbreaks to decrease transmission 2, 3
- First-line oral options for MSSA:
- Alternative oral options:
When to Cover MRSA
If MRSA is suspected (based on local prevalence, previous MRSA infection, or treatment failure), use MRSA-active antibiotics: 1
- Clindamycin 300-450 mg four times daily for 7 days 1
- Trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets twice daily for 7 days 1
- Doxycycline or minocycline 100 mg twice daily for 7 days 1
Important MRSA Coverage Caveat
- TMP-SMX provides excellent MRSA coverage but inadequate streptococcal coverage 4
- If streptococcal infection is suspected and TMP-SMX is used, consider adding a beta-lactam like amoxicillin 1
- Clindamycin covers both MRSA and streptococci, making it the preferred single-agent option when MRSA is suspected 1, 4
Critical Treatment Considerations
Antibiotics to Avoid
- Penicillin alone is seldom effective for impetigo and should only be used when cultures confirm streptococci alone 2, 3
- Amoxicillin alone lacks adequate coverage against S. aureus, which is now the predominant causative organism 2
- Topical disinfectants are inferior to antibiotics and should not be used 4, 3
Treatment Duration
Resistance Patterns
- Methicillin-resistant S. aureus (MRSA), macrolide-resistant streptococcus, and mupirocin-resistant streptococcus are all documented 4
- In areas with high MRSA prevalence (>10% resistance), empiric therapy should cover MRSA until culture results are available 1, 2
- Erythromycin resistance rates are rising, limiting its utility 1, 4
When to Obtain Cultures
Cultures are not routinely recommended for typical impetigo 1
Cultures should be obtained in the following situations: 1
- Patients treated with antibiotic therapy who fail to respond
- Patients with severe local infection or signs of systemic illness
- Concern for a cluster or outbreak
- To guide therapy when MRSA is suspected
Prevention of Spread
- Keep draining wounds covered with clean, dry bandages 1, 2
- Maintain good personal hygiene with regular handwashing using soap and water or alcohol-based hand gel 1, 2
- Avoid reusing or sharing personal items (razors, linens, towels) that have contacted infected skin 1, 2
Special Clinical Scenarios
Recurrent Impetigo
- Drain and culture recurrent abscesses early 1
- Consider a 5-day decolonization regimen with intranasal mupirocin twice daily, daily chlorhexidine washes, and daily decontamination of personal items 1
Outbreaks of Poststreptococcal Glomerulonephritis
- Systemic antimicrobials should be used during outbreaks to eliminate nephritogenic strains 2